Advanced Proteomics Approaches Hold Potential for the Risk Assessment of Metabolism-Disrupting Chemicals as Omics-Based NAM: A Case Study Using the Phthalate Substitute DINCH
Aldehoff AS., Karkossa I., Broghammer H., Krupka S., Weiner J., Goerdeler C.
Animal Study, published in Environ Sci Technol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Environ Sci Technol (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40736767
- PMCID
- PMC12355959
- DOI
- 10.1021/acs.est.5c01206
- Citations
- 1
Abstract (original English)
The concept of metabolic disruption through exposure to chemicals has expanded our understanding of how environmental pollution can contribute to metabolic dysregulation and, ultimately, diseases like obesity. New strategies for assessing the risks posed by chemicals are needed, and omics technologies, including proteomics, have proven to be powerful tools for investigating the molecular mechanisms of these metabolism-disrupting chemicals (MDCs). A potential MDC is the plasticizer DINCH─an alternative to legacy phthalates like DEHP, whose primary metabolite MINCH has been linked to the induction of adipogenesis and lipid accumulation. Here, global proteomics was complemented with insights into protein thermal stability and the profiles of post-translational modification (PTM) acetylation and phosphorylation to provide a profound understanding of chemical-induced metabolic disruption in adipocytes. We demonstrate the utility of advanced proteomics approaches in assessing the effects of potential MDCs by using the human SGBS adipocyte cell line. Adipose tissue PTM data from dietary DINCH-exposed mice were assessed as an in vivo model, and in vitro data shed light on DINCH's molecular effects, including protein interactions beyond its primary target PPARγ. The results emphasize the potential of omics approaches to enhance current risk assessment frameworks for emerging contaminant
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.